[{"address1": "100 Campus Drive", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "608 441 8120", "website": "https://www.cellectar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r pediatric patients with head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.", "fullTimeEmployees": 15, "companyOfficers": [{"maxAge": 1, "name": "Mr. James V. Caruso", "age": 64, "title": "President, CEO & Director", "yearBorn": 1959, "fiscalYear": 2022, "totalPay": 846475, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chad J. Kolean CPA", "age": 59, "title": "VP, CFO & Secretary", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 453224, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jarrod  Longcor", "age": 50, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 625320, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Darrell Shane Lea", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrei  Shustov M.D.", "age": 52, "title": "Senior Vice President of Medical", "yearBorn": 1971, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.05, "open": 4.1, "dayLow": 3.99, "dayHigh": 4.215, "regularMarketPreviousClose": 4.05, "regularMarketOpen": 4.1, "regularMarketDayLow": 3.99, "regularMarketDayHigh": 4.215, "beta": 0.93, "forwardPE": -1.413145, "volume": 905107, "regularMarketVolume": 905107, "averageVolume": 1685808, "averageVolume10days": 1199340, "averageDailyVolume10Day": 1199340, "bid": 4.1, "ask": 4.08, "bidSize": 900, "askSize": 800, "marketCap": 49143372, "fiftyTwoWeekLow": 1.3, "fiftyTwoWeekHigh": 4.45, "fiftyDayAverage": 3.4408, "twoHundredDayAverage": 2.4468, "currency": "USD", "enterpriseValue": 50652308, "floatShares": 9203833, "sharesOutstanding": 12288300, "sharesShort": 2365336, "sharesShortPriorMonth": 1666384, "sharesShortPreviousMonthDate": 1705017600, "dateShortInterest": 1707955200, "sharesPercentSharesOut": 0.1925, "heldPercentInsiders": 0.03782, "heldPercentInstitutions": 0.32277, "shortRatio": 1.7, "shortPercentOfFloat": 0.19309999, "impliedSharesOutstanding": 12288300, "bookValue": -1.486, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -37749932, "trailingEps": -3.26, "forwardEps": -2.83, "lastSplitFactor": "1:10", "lastSplitDate": 1658448000, "enterpriseToEbitda": -1.504, "52WeekChange": 1.1315789, "SandP52WeekChange": 0.27220368, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CLRB", "underlyingSymbol": "CLRB", "shortName": "Cellectar Biosciences, Inc.", "longName": "Cellectar Biosciences, Inc.", "firstTradeDateEpochUtc": 1131633000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d92a6d57-8c29-3e38-89dc-584b57cac7f0", "messageBoardId": "finmb_37613299", "gmtOffSetMilliseconds": -18000000, "currentPrice": 3.9992, "targetHighPrice": 25.0, "targetLowPrice": 4.0, "targetMeanPrice": 12.6, "targetMedianPrice": 12.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 18986444, "totalCashPerShare": 1.545, "ebitda": -33674728, "totalDebt": 569013, "quickRatio": 1.153, "currentRatio": 1.221, "debtToEquity": 12.459, "returnOnAssets": -1.03484, "returnOnEquity": -4.3597, "freeCashflow": -10114315, "operatingCashflow": -30193036, "financialCurrency": "USD", "trailingPegRatio": null}]